Costs of pharmacotherapy in pediatric patients with community-acquired pneumonia: mathematical and statistical analysis

The aim of the study is to determine the limits of using the mathematical-statistical analysis for the evaluation of pharmacotherapy costs in pediatric inpatients diagnosed with community-acquired pneumonia. Materials and methods. The report is based on the assessment of 547 medical records of patients with community-acquired pneumonia, who underwent the treatment in four pediatric hospitals in St. Petersburg. The data array was created from a number of factors that characterize the patients’ profile (gender, duration of hospital stay, cost of therapy, number of prescribed drugs, number of affected lung segments, pathogen location, leukocyte count, and eSR). Results. Correlation analysis allowed us to identify factors contributing to the cost of pharmacotherapy (at a significance of p=0.05); those were: the duration of hospital stay (r=0.34), the number of prescribed drugs (r=0.26), and the number of affected lung segments (r=0.21). Dispersion analysis of qualitative factors (gender, location of pneumonic infiltrate) showed no significant impact of these factors on the costs or the number of prescribed drugs in the total data set. From the regression analysis, we obtained formulas for the dependence of the resulting parameters (cost of pharmacotherapy, number of prescribed drugs) on a set of independent variables. Conclusion. The treatment cost optimization in pediatric patients with community-acquired pneumonia should include the use of antibacterial drugs with proven efficacy and safety, as well as a reduction in non-necessary supporting therapy, e.g., medications aimed to correct morphological and functional changes in the respiratory system.

1. Order of the Government of the Russian Federation of 12.01.2018, No. 9-p. On the plan of measures («road map») «Development of competition in healthcare» (in Russian).

2. Siukaeva D. D., Nemyatyh O. D. Community-acquired pneumonia in pediatrics: tactics of pharmacological correction and central aspects of pharmacoeconomics. Meditsinskiy vestnik Bashkortostana. 2016; 6 (66): 11: 114-118 (in Russian).

3. Narkevich I.A., Nemyatyh O.D., Kuldyrkaeva E.V., Shumlyanskaya V.E., Siukaeva D.D. Pharmacovigilance System: International experience and prospects in Russia. Farmatsiya. 2016; 7 (65): 3-7 (in Russian).

4. Narkevich I. A., Nemyatyh O. D., Basakina I. I., Siukaeva D. D. Pharmaceutical Drug Development for Pediatric Practice: Fundamentals and Specific Features. Razrabotka i registratsiya lekarstvennyh sredstv. 2016; 3 (16): 194-201 (in Russian).

5. Zubov N. N. Methods of statistical analysis of data in medicine and pharmacy: a tutorial / N. N. Zubov, V. I. Kuvakin / under total. ed. Associate Professor N. N. Zubova. SPb. 2017; 216 p (in Russian).

6. Ponomareva E. A. Formation of an optimal range of antibiotics for the inpatient treatment of children (using the example of community-acquired pneumonia). MD diss. 14.04.03. Perm. 2012; 25 s (in Russian).

7. Varavina E. A. Pharmacoeconomic analysis of antibacterial therapy of community-acquired pneumonia. MD diss. 14.00.25.Vladivostok. 2004; 28 s (in Russian).

8. Narkevich I. A. Scientific basis for rationing medical equipment in the Armed Forces of the Russian Federation. MD diss. 15.00.01.SPb. 2001; 39 s (in Russian).

9. Rebrova O. Yu. Statistical analysis of medical data. Application of application method STATISTICA. O. Yu. Rebrova. Media Sphere. Moscow. 2003; 312 p (in Russian).

10. Zubov N. N. Mathematical methods and models in pharmaceutical science and practice: a guide for pharmacists and managers of pharmaceutical enterprises (organizations) / N. N. Zubov, S. Z. Umarov, S. A. Bunin. SPb. 2008; 249 p (in Russian).

11. Avksenteva M. V. Clinical-statistical groups (CSG) as a new method of payment for inpatient and hospital-replacing care in the Russian Federation / M. V. Avksentiev, S. K. Salakhutdinova. Medicinal Bulletin. 2016; 2 (62). T.10: 31-36 (in Russian).

12. Letter of the Ministry of Health of Russia No. 11-9 / 10 / 2-7938 and FFOMS No. 8089/21 dated 12/24/2015 «On methodological recommendations on how to pay for medical care at the expense of compulsory medical insurance» (in Russian).

13. Siukaeva D. D., Narkevich I. A., Timchenko V. N., Nemyatyh O. D., Maslova N. A. Use of medications in children hospitalized with community-acquired pneumonia. FARMAKOEKONOMIKA. Sovremennaya farmakoekonomika i farmakoepidemiologiya / FARMAKOEKONOMIKA. Modern pharmacoeconomics and pharmacoepidemiology. 2018; 11(3): 8-12. DOI: https://doi.org/10.17749/2070-4909.2018.11.3-008-012 (in Russian).